4.2 Article

MiR-22 may Suppress Fibrogenesis by Targeting TGF beta R I in Cardiac Fibroblasts

Journal

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
Volume 40, Issue 6, Pages 1345-1353

Publisher

KARGER
DOI: 10.1159/000453187

Keywords

Myocardial infarction; Cardiac fibrosis; MicroRNA-22; TGF beta R

Funding

  1. Wuxi Municipal Science and Technology Bureau [CSZ0N1405, CSZ0N1624]
  2. Pharmaceutical Foundation of the Management Center of Wuxi Hospital [YGZXY1314]

Ask authors/readers for more resources

Background/Aims: Cardiac fibrosis after myocardial infarction (MI) has been identified as a key factor in the development of heart failure, but the mechanisms undelying cardiac fibrosis remained unknown. microRNAs (miRNAs) are novel mechanisms leading to fibrotic diseases, including cardiac fibrosis. Previous studies revealed that miR-22 might be a potential target. However, the roles and mechanisms of miR-22 in cardiac fibrosis remained ill defined. The present study thus addressed the impact of miR-22 in cardiac fibrosis. Methods: After seven days following coronary artery occlusion in mice, tissues used for histology were collected and processed for Masson's Trichrome staining. In addition, cardiac fibroblasts were transfected with mimics and inhibitors of miR-22 using Lipofectamin 2000, and luciferase activity was measured in cell lysates using a luciferase assay kit. Western blotting was used to detect the expression of collagenl, alpha-SMA and TGF beta RI proteins levels, and real time-PCR was employed to measure the Col1 alpha 1, Col3 alpha 1, miR-22 and TGF beta RI mRNA levels. Results: In this study, we found that miR-22 was dynamically downregulated following MI induced by permanent ligation of the left anterior descending coronary artery for 7 days, an effect paralleled by significant collagen deposition. Inhibition of miR-22 with AMO-22 resulted in increased expression of Col1 alpha 1. Col3 alpha 1 and fibrogenesis in cultured cardiac fibroblasts. Conversely, overexpression of miR-22 in cultured cardiac fibroblasts significantly abrogated angiotensin II-induced collagen formation and fibrogenesis. Furthermore, we found that TGF beta RI is a direct target for miR-22, and downregulation of TGF beta R may have mediated the antifibrotic effect of miR-22. Conclusion: Our data clearly demonstrate that miR-22 acts as a novel negative regulator of angiotensin II-induced cardiac fibrosis by suppressing the expression of TGF beta RI in the heart and may represent a new potential therapeutic target for treating cardiac fibrosis. (C) 2016 The Author(s) Published by S. Karger AG, Basel

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available